Asset Manager

Updated:

PatientPop

PatientPop rebranded as Tebra, serving 150,000 providers with EHR, billing, scheduling, and AI practice marketing for independent medical practices.

PatientPop

PatientPop was founded in 2014 by Luke Kervin and Christine Caragianis (per company history sources, 2014). The firm initially focused on practice growth and reputation management for independent healthcare providers before merging with Kareo in 2021 to form Tebra. Wealth origin for the founding team is not publicly disclosed. Tebra's platform combines EHR, billing, scheduling, and medical practice marketing into a single interface. The company targets independent practices across multiple specialties, offering AI-generated clinical notes, online scheduling, claims management, and reputation tools. It operates primarily in the US and Canada. Named portfolio companies or co-investors are not disclosed on the firm's website. The firm claims 150,000 providers as users and maintains multiple offices across the US including Irvine, Boston, Santa Monica, and New York. Tebra does not disclose employee count or funding details. No recent operational event from the last 24 months was publicly reported. Tebra's structural differentiator is the unification of clinical and practice management under one brand, merging PatientPop's marketing focus with Kareo's billing heritage. The platform is built to serve small to mid-size private practices, a segment often underserved by larger EHR vendors.

General information

Firm type

Asset Manager

Year founded

AUM

Undisclosed

Location

Region

North America

Country

United States

City

Irvine

Corporate office

Irvine, CA, United States

Additional offices

Boston · Santa Monica · New York · San Francisco · Palo Alto · Menlo Park · Fremont · Portola Valley · Watertown · Wilton · Owings Mills · Santa Clara

Sector focus

Digital HealthHealthcare ServicesEnterprise SoftwareAI/ML

Frequently asked questions

Who runs investment decisions at PatientPop?

PatientPop does not publicly disclose investment principals. The firm rebranded as Tebra in 2021 following a merger with Kareo. Leadership details for the combined entity are not published on the company website.

How does PatientPop source proprietary deal flow?

PatientPop does not operate as an investment firm and does not source external deals. It sells its SaaS platform directly to independent medical practices through digital marketing, partner referrals, and a field sales team.

Is PatientPop structured as a family office or a venture firm?

PatientPop is a private SaaS company, not a family office, asset manager, or venture firm. It was originally backed by venture capital investors including Athyrium Capital Management (per PitchBook, 2020).

Does PatientPop participate in fund commitments or direct investments?

No. PatientPop's business is selling EHR and practice management software. It does not invest in external funds or make direct equity investments.

What investment stages does PatientPop typically target?

PatientPop is not an investment firm. The company targets independent medical practices of any stage for its software platform.

Which sectors does PatientPop explicitly avoid?

PatientPop focuses exclusively on healthcare. It does not serve non-medical businesses, hospitals, or large health systems, though it does not publicly state any explicit avoidance list.

How is PatientPop related to Tebra?

PatientPop merged with Kareo in 2021 and the combined entity rebranded as Tebra. The domain patientpop.com now redirects to tebra.com, and the company markets itself solely as Tebra.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo